María Luisa Limón Mirón

Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study

Michael J. Overman, Fabio Gelsomino, Massimo Aglietta et al. · Journal for ImmunoTherapy of Cancer · 2024 · 53 citations · Full text

Life Sciences, Immunology, Oncology +17

Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer

David R. Fogelman, Antonio Cubillo, Pilar García‐Alfonso et al. · Cancer Medicine · 2018 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

Effects of depression and cognitive impairment on quality of life in older adults with schizophrenia spectrum disorder: Results from a multicenter study

Rachel Pascal de Raykeer, Nicolas Hoertel, Carlos Blanco et al. · Journal of Affective Disorders · 2019 · 32 citations · Full text

Medicine, Geriatric Medicine, Psychiatry +17

Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C

Khaldoun Almhanna, María Luisa Limón Mirón, David Wright et al. · Investigational New Drugs · 2017 · 23 citations

Medicine, Oncology, Pharmacology +17